Unassociated Document
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act 1934
Date
of
Report (date of earliest event reported): November
17, 2008
GENESIS
PHARMACEUTICALS ENTERPRISES, INC.
(Exact
name of registrant as specified in charter)
Florida
(State
or
other jurisdiction of incorporation)
333-86347 65-1130026
(Commission
File Number) (IRS
Employer Identification No.)
|
Middle
Section, Longmao Street, Area A, Laiyang Waixiangxing Industrial
Park
|
|
Laiyang
City, Yantai, Shandong Province, People’s Republic of China
265200
|
(Address
of principal executive offices and zip code)
(0086)535-7282997
(Registrant's
telephone number including area code)
(Registrant's
former name or former address, if changed since last report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of registrant under any of the following
provisions:
[
]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[
]
Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR
240.14a-12(b))
[
]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act
(17 CFR 240.14d-2(b))
[
]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act
(17 CFR 240.13e-4(c))
Item
2.02 Results
of Operations and Financial Condition.
On
November 17, 2008, Genesis Pharmaceuticals Enterprises, Inc. (the
“Company”) issued a press release and hosted a conference call during which the
Company’s operating results for the first quarter of 2009 was discussed. A copy
of the press release is attached hereto as Exhibit 99.1.
Item
9.01 Financial
Statements and Exhibits.
|
Exhibit
No.
|
|
Description
|
|
99.1
|
|
Press
Release dated November 17,
2008.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
|
|
| |
GENESIS
PHARMACEUTICALS ENTERPRISES, INC. |
|
|
|
| |
By: |
/s/ Wubo
Cao |
| |
Name:
Wubo Cao
Title:
Chief Executive Officer
|
|
Dated:
November 18, 2008
|
|